If damaged cells are replaceable, type 1 diabetics wouldn’t need insulin shots
Signaling a potential new approach to treating diabetes, researchers at Washington University School of Medicine in St. Louis and Harvard University have produced insulin-secreting cells from stem cells derived from patients with type 1 diabetes.
People with this form of diabetes can’t make their own insulin and require regular insulin injections to control their blood sugar. The new discovery suggests a personalized treatment approach to diabetes may be on the horizon — one that relies on the patients’ own stem cells to manufacture new cells that make insulin.
The researchers showed that the new cells could produce insulin when they encountered sugar. The scientists tested the cells in culture and in mice, and in both cases found that the cells secreted insulin in response to glucose.
The research is published May 10 in the journal Nature Communications.
“In theory, if we could replace the damaged cells in these individuals with new pancreatic beta cells — whose primary function is to store and release insulin to control blood glucose — patients with type 1 diabetes wouldn’t need insulin shots anymore,” said first author Jeffrey R. Millman, PhD, an assistant professor of medicine and of biomedical engineering at Washington University School of Medicine. “The cells we’ve manufactured sense the presence of glucose and secrete insulin in response. And beta cells do a much better job controlling blood sugar than diabetic patients can.”
Millman, whose laboratory is in the Division of Endocrinology, Metabolism and Lipid Research, began his research while working in the laboratory of Douglas A. Melton, PhD, Howard Hughes Medical Institute investigator and a co-director of Harvard’s Stem Cell Institute. There, Millman had used similar techniques to make beta cells from stem cells derived from people who did not have diabetes. In these new experiments, the beta cells came from tissue taken from the skin of diabetes patients.
“There had been questions about whether we could make these cells from people with type 1 diabetes,” Millman explained. “Some scientists thought that because the tissue would be coming from diabetes patients, there might be defects to prevent us from helping the stem cells differentiate into beta cells. It turns out that’s not the case.”
Millman said more research is needed to make sure that the beta cells made from patient-derived stem cells don’t cause tumors to develop — a problem that has surfaced in some stem cell research — but there has been no evidence of tumors in the mouse studies, even up to a year after the cells were implanted.
The Latest on: Patient-derived stem cells
via Google News
The Latest on: Patient-derived stem cells
- Cell-Cell Communication in The Tumor Microenvironment on February 15, 2019 at 8:56 am
Non-cancer microenvironment cells include stromal cells which can be mesenchymal stem cells (MSC) and their derivatives ... the leukemia cells do not grow. The reason patient-derived xenograft models ... […]
- Brain Tumors on February 13, 2019 at 5:47 am
Primary brain tumors form in brain tissue because of abnormal cell growth and can occur in several different ... drugs – Fred Hutch researchers have created the world's first patient-derived models fo... […]
- Researchers develop powerful new approach to improve maturation of miniature kidneys on February 13, 2019 at 3:27 am
that affect specific structures and cell types using patient-derived stem cells as the starting point,” said co-corresponding author Lewis, Sc.D., who is a Core Faculty member of the Wyss Institute an... […]
- Engineered miniature kidneys come of age on February 12, 2019 at 6:40 am
that affect specific structures and cell types using patient-derived stem cells as the starting point," said co-corresponding author Lewis, Sc.D., who is a Core Faculty member of the Wyss Institute an... […]
- Engineered mini-kidneys come of age on February 11, 2019 at 8:10 am
“This important advance opens up new avenues for accurately testing drug toxicity in vitro … and modeling kidney diseases, like polycystic kidney disease, that affect specific structures and cell type... […]
- Automated microfluidic cell culture of stem cell derived dopaminergic neurons on February 11, 2019 at 2:44 am
Using this system, we continuously monitored the differentiation of Parkinson’s disease patient derived human neuroepithelial stem cells into midbrain specific dopaminergic neurons. Calcium imaging co... […]
- 3D Cell Culture takes place in 2 weeks on February 8, 2019 at 5:28 am
who will be speaking on ‘Co-clinical trials using patient-derived organoids in metastatic gastrointestinal cancers.’ 3D Cell Culture has attracted a truly global audience of clinical ... […]
- This Company is Advancing Immuno-Oncology Research with its Full Human Immune System Mouse Models on February 6, 2019 at 1:24 am
The engrafted human stem cells mature and develop a fully functional ... Tumors cells are then injected from that moment onwards using cancer-type cell lines or patient-derived tumor cells (PDX). “Man... […]
- Scientists generate, track development of myelin-producing brain cells on January 28, 2019 at 8:27 am
Generating brain spheroids from patient-derived skin cells allows medical researchers such ... Stanford investigators fused two stem-cell-derived neural spheroids, each containing a different type of ... […]
- Rice, Duke researchers define a small protein’s central role in tumor mechanics on January 2, 2019 at 4:00 pm
“We are now using these patient-derived tumor organoid models to identify druggable targets in the notch signaling pathway.” Bocci said mesenchymal stem cells tend to remain near a tumor’s periphery, ... […]
via Bing News